anti-MCP4 Liquid antibody product blog
Tags: Antibody; Monoclonal Antibody; MCP4 Liquid; anti-MCP4 Liquid antibody;
The MCP4 Liquid n/a (Catalog #MBS605342) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The MCP4 Liquid (Macrophage/Monocyte Chemotactic Protein 4) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s MCP4 Liquid can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB), Neutralization.Suitable for use in ELISA, Neutralization and Western Blot.
Dilution: ELISA: 2-4ug/ml (100ul/well). Use as capture antibody in sandwich ELISA.
Neutralization: 0.8-1ug/ml
Western Blot: 0.25-0.50ug/ml. Detection limit is 0.5-1ng/lane, under reducing and non-reducing conditions.
Optimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the MCP4 Liquid n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Human macrophage/monocyte chemotactic protein-4 (MCP-4) is a member of the b-chemokine family (C-C) of cytokines. Like eotaxin, MCP-4 is a powerful eosinophil chemoattractant. Additionally, like MCP-3, MCP-4 elicits chemoattraction of monocytes and T lymphocytes.
Immunogen: Recombinant human MCP-4. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MCP4 Liquid are readily searchable from our website. Different antibodies against the same target such as MCP4 Liquid may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.